Search

Displaying results 9281 - 9290 of 10000 in total
  1. Drug

    PHA-793887

    go.drugbank.com/drugs/DB12686
    Investigational

    PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.

  2. Drug

    Glial growth factor 2

    go.drugbank.com/drugs/DB12841
    Investigational

    Glial growth factor 2 has been used in trials studying the treatment of Heart Failure.

  3. Drug

    BMS-908662

    go.drugbank.com/drugs/DB12854
    Investigational

    BMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.

  4. Drug

    Calcitonin eel

    go.drugbank.com/drugs/DB12898
    Investigational

    HC-58 has been used in trials studying the prevention of Severe Upper Limb Hemiplegia.

  5. Drug

    Nikkomycin Z

    go.drugbank.com/drugs/DB12939
    Investigational

    Nikkomycin Z has been used in trials studying the treatment and basic science of Coccidioidomycosis.

  6. Drug

    Pactimibe

    go.drugbank.com/drugs/DB12971
    Investigational

    Pactimibe has been used in trials studying the treatment of Atherosclerosis and Coronary Heart Disease.

  7. Drug

    PKI-179

    go.drugbank.com/drugs/DB13109
    Investigational

    PKI-179 has been used in trials studying the treatment of Advanced Malignant Solid Tumors.

  8. Drug

    P-BCMA-101

    go.drugbank.com/drugs/DB17371
    Investigational

    P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.

    Synonyms: Autologous T-cells transfected with PiggyBac transposon plasmid vector expressing B-cell maturation antigen (CAR-T cells)
  9. Drug

    AAV-RPE65

    go.drugbank.com/drugs/DB18343
    Experimental

    AAV-RPE65 is an adenovirus associated viral vector serotype 5 containing the human RPE65 gene

  10. Drug

    WU-NK-101

    go.drugbank.com/drugs/DB18350
    Investigational

    WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product